Summit Place Financial Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-9,354
Closed -$237K 96
2025
Q1
$237K Buy
9,354
+630
+7% +$16.5K 0.13% 88
2024
Q4
$231K Hold
8,724
0.13% 83
2024
Q3
$252K Hold
8,724
0.14% 86
2024
Q2
$244K Sell
8,724
-26
-0.3% -$716 0.14% 85
2024
Q1
$243K Hold
8,750
0.14% 87
2023
Q4
$252K Sell
8,750
-29
-0.3% -$877 0.16% 82
2023
Q3
$291K Buy
8,779
+29
+0.3% +$1.03K 0.21% 81
2023
Q2
$321K Hold
8,750
0.21% 79
2023
Q1
$357K Hold
8,750
0.25% 77
2022
Q4
$448K Hold
8,750
0.37% 65
2022
Q3
$383K Hold
8,750
0.36% 70
2022
Q2
$459K Sell
8,750
-300
-3% -$15.3K 0.39% 75
2022
Q1
$469K Hold
9,050
0.31% 79
2021
Q4
$534K Sell
9,050
-525
-5% -$26K 0.37% 72
2021
Q3
$412K Sell
9,575
-5,613
-37% -$249K 0.3% 80
2021
Q2
$595K Sell
15,188
-14,391
-49% -$560K 0.44% 68
2021
Q1
$1.07M Sell
29,579
-28,095
-49% -$998K 0.86% 47
2020
Q4
$2.12M Sell
57,674
-2,836
-5% -$104K 1.84% 19
2020
Q3
$2.11M Sell
60,510
-2,582
-4% -$90.5K 2.11% 7
2020
Q2
$1.96M Buy
63,092
+15,045
+31% +$511K 3.1% 7
2020
Q1
$1.49M Buy
48,047
+7,062
+17% +$241K 3.18% 12
2019
Q4
$1.52M Buy
+40,985
New +$1.46M 2.41% 21

Other funds holding PFE

Summit Place Financial Advisors's PFE Position: Q2 2025 in Review

Summit Place Financial Advisors sold out of Pfizer (PFE) in Q2 2025, closing a stake of 9,354 shares — an estimated $237K sold.

Summit Place Financial Advisors first reported a position in PFE in Q4 2019 and held it in 22 quarters. The position peaked at $2.12M in Q4 2020. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • Summit Place Financial Advisors reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
  • Summit Place Financial Advisors sold 9,354 Pfizer shares in Q2 2025, an estimated $237K.
  • Summit Place Financial Advisors first reported a position in Pfizer in Q4 2019 and held it in 22 quarters.
  • Summit Place Financial Advisors's Pfizer position peaked at $2.12M in Q4 2020.
  • 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Summit Place Financial Advisors's 13F filing for Q2 2025, filed 24 Jul 2025.